Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

The expert panel further added, "The safety and efficacy data are to be deliberated in the presence of an independent expert ...

However, Paul Hudson, CEO of Sanofi, one of the world's leading biopharmaceutical companies, says executives may need to rein ...

Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...

Among these, Bristol Myers Squibb, Gilead Sciences and Sanofi stood out with robust growth ... bolstered by the still high ...

New advancements in Cold Agglutinin Disease treatments promise improved patient outcomes and market growth, driving innovation and investment in the sector.

This demonstrated the power of AI in drug discovery especially for novel targets.” Insilico has elected to bring this program in-house following a reprioritization by Sanofi. The companies ...

New Delhi: The drug major Sanofi Healthcare has got approval from the Subject Expert Committee (SEC) functional under the ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission (EC) to treat eosinophilic ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...